Approval · Notice of Compliance 24090 · 2020
VEMLIDY: Notice of Compliance 24090
Issued August 21, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24090
- Date
- August 21, 2020
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the Product Monograph with renal effects for tenofovir alafenamide.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VEMLIDY | Not yet assigned | — |
Medicinal ingredients
- TENOFOVIR ALAFENAMIDE 25 MG per TAB